SE9002278L - Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel - Google Patents

Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel

Info

Publication number: SE9002278L
Authority: SE; Sweden
Prior art keywords: medicine; preparation; application; inositol trisphosphate; effective
Prior art date: 1990-06-28

Application number

SE9002278A

Other languages

Unknown language ( )

English (en)

Swedish (sv)

Other versions

SE9002278D0 (sv

Inventor

M Siren

Original Assignee

Perstorp Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-06-28

Filing date

1990-06-28

Publication date

1991-12-29

1990-06-28 Application filed by Perstorp Ab filed Critical Perstorp Ab

1990-06-28 Priority to SE9002278A priority Critical patent/SE9002278L/

1990-06-28 Publication of SE9002278D0 publication Critical patent/SE9002278D0/xx

1991-06-19 Priority to AU81886/91A priority patent/AU8188691A/en

1991-06-19 Priority to ES91912558T priority patent/ES2115616T3/es

1991-06-19 Priority to DK91912558T priority patent/DK0536269T3/da

1991-06-19 Priority to EP93101712A priority patent/EP0554861A1/de

1991-06-19 Priority to AT91912558T priority patent/ATE165514T1/de

1991-06-19 Priority to PCT/SE1991/000439 priority patent/WO1992000079A1/en

1991-06-19 Priority to EP91912558A priority patent/EP0536269B1/de

1991-06-19 Priority to DE69129331T priority patent/DE69129331T2/de

1991-06-19 Priority to US07/966,035 priority patent/US5284839A/en

1991-06-27 Priority to JP3156823A priority patent/JPH0639383B2/ja

1991-12-29 Publication of SE9002278L publication Critical patent/SE9002278L/

Links

MMWCIQZXVOZEGG-UHFFFAOYSA-N 1,4,5-IP3 Natural products OC1C(O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(O)C1OP(O)(O)=O MMWCIQZXVOZEGG-UHFFFAOYSA-N 0.000 title abstract 4
MMWCIQZXVOZEGG-XJTPDSDZSA-N D-myo-Inositol 1,4,5-trisphosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1OP(O)(O)=O MMWCIQZXVOZEGG-XJTPDSDZSA-N 0.000 title abstract 4
239000005557 antagonist Substances 0.000 abstract 1
230000002490 cerebral effect Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000002526 effect on cardiovascular system Effects 0.000 abstract 1
BPGXUIVWLQTVLZ-OFGSCBOVSA-N neuropeptide y(npy) Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 BPGXUIVWLQTVLZ-OFGSCBOVSA-N 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Hematology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SE9002278A 1990-06-28 1990-06-28 Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel SE9002278L (sv)

Priority Applications (11)

Application Number	Priority Date	Filing Date	Title
SE9002278A SE9002278L (sv)	1990-06-28	1990-06-28	Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel
US07/966,035 US5284839A (en)	1990-06-28	1991-06-19	Use of inositoltrisphosphate to treat abnornal gastrointestinal motility and secretion
EP93101712A EP0554861A1 (de)	1990-06-28	1991-06-19	Verwendung von Inositoltriphosphat zur Behandlung von Nierenerkrankungen
ES91912558T ES2115616T3 (es)	1990-06-28	1991-06-19	Utilizacion de inositoltrisfosfato en la preparacion de medicamentos.
DK91912558T DK0536269T3 (da)	1990-06-28	1991-06-19	Anvendelse af inositol-triphosphat til fremstilling af medikamenter
AU81886/91A AU8188691A (en)	1990-06-28	1991-06-19	The use of inositoltrisphosphate for the preparing of medicaments
AT91912558T ATE165514T1 (de)	1990-06-28	1991-06-19	Verwendung von inosittriphosphat zur zubereitung von medikamenten
PCT/SE1991/000439 WO1992000079A1 (en)	1990-06-28	1991-06-19	The use of inositoltrisphosphate for the preparing of medicaments
EP91912558A EP0536269B1 (de)	1990-06-28	1991-06-19	Verwendung von inosittriphosphat zur zubereitung von medikamenten
DE69129331T DE69129331T2 (de)	1990-06-28	1991-06-19	Verwendung von inosittriphosphat zur zubereitung von medikamenten
JP3156823A JPH0639383B2 (ja)	1990-06-28	1991-06-27	医薬組成物

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9002278A SE9002278L (sv)	1990-06-28	1990-06-28	Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel

Publications (2)

Publication Number	Publication Date
SE9002278D0 SE9002278D0 (sv)	1990-06-28
SE9002278L true SE9002278L (sv)	1991-12-29

Family

ID=20379887

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE9002278A SE9002278L (sv)	1990-06-28	1990-06-28	Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel

Country Status (10)

Country	Link
US (1)	US5284839A (de)
EP (2)	EP0536269B1 (de)
JP (1)	JPH0639383B2 (de)
AT (1)	ATE165514T1 (de)
AU (1)	AU8188691A (de)
DE (1)	DE69129331T2 (de)
DK (1)	DK0536269T3 (de)
ES (1)	ES2115616T3 (de)
SE (1)	SE9002278L (de)
WO (1)	WO1992000079A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9213215D0 (en) *	1992-06-20	1992-08-05	Wellcome Found	Peptides
IT1265647B1 (it) *	1992-11-18	1996-11-22	Farmin Srl	Composizione farmaceutiche topiche per le allergie respiratorie
US5827837A (en) *	1993-08-20	1998-10-27	The Regents Of The University Of California	Polyanion anti-inflammatory agents
US5516653A (en) *	1993-12-28	1996-05-14	Synaptic Pharmaceutical Corporation	DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
US5545549A (en)	1994-02-03	1996-08-13	Synaptic Pharmaceutical Corporation	DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
US5602024A (en)	1994-12-02	1997-02-11	Synaptic Pharmaceutical Corporation	DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof
US5989920A (en)	1994-12-02	1999-11-23	Synaptic Pharmaceutical Corporation	Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5
US7048906B2 (en) *	1995-05-17	2006-05-23	Cedars-Sinai Medical Center	Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
FR2754709B1 (fr)	1996-10-23	1999-03-05	Sanofi Sa	Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
US6713265B1 (en)	1997-06-04	2004-03-30	Synaptic Pharmaceutical Corporation	Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
CN1135983C (zh) *	2001-06-28	2004-01-28	中山大学	二酸（5－雄甾烯－17－酮－3β－羟基）二酯用于制备药物
GB0121709D0 (en) *	2001-09-07	2001-10-31	Imp College Innovations Ltd	Food inhibition agent
AU2002353784B2 (en) *	2001-09-24	2008-04-10	Oregon Health And Science University	Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
PL205971B1 (pl)	2001-09-24	2010-06-30	Imp Innovations Ltd	Zastosowanie PYY₃-₃₆ do wytwarzania leku na ograniczanie apetytu, zmniejszenie otyłości lub do zapobiegania otyłości
AU2003201998C1 (en)	2002-01-10	2012-10-25	Imperial Innovations Limited	Modification of feeding behavior
US8058233B2 (en) *	2002-01-10	2011-11-15	Oregon Health And Science University	Modification of feeding behavior using PYY and GLP-1
KR20040051455A (ko) *	2002-12-12	2004-06-18	아미코젠주식회사	산화적 손상을 예방하기 위한 카이로이노시톨 또는피니톨의 용도 및 이들을 함유하는 당뇨합병증 예방용조성물
GB0300571D0 (en) *	2003-01-10	2003-02-12	Imp College Innovations Ltd	Modification of feeding behaviour
GB0511986D0 (en) *	2005-06-13	2005-07-20	Imp College Innovations Ltd	Novel compounds and their effects on feeding behaviour
TWI428346B (zh) *	2006-12-13	2014-03-01	Imp Innovations Ltd	新穎化合物及其等對進食行為影響
EP2451459B1 (de) *	2009-07-07	2017-11-22	Normoxys, Inc.	Verfahren zur reduzierung einer multiresistenz gegen arzneimittel mittels inositol-tripyrophosphat

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE465951B (sv) *	1984-10-23	1991-11-25	Perstorp Ab	Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
SE465305B (sv) *	1986-04-16	1991-08-26	Perstorp Ab	Anvaendning av inositolfosfat foer framstaellning av ett laekemedel
SE464059C (sv) *	1988-09-15	1997-06-02	Perstorp Ab	Användning av inositoltrifosfat för framställning av läkemedel

1990
- 1990-06-28 SE SE9002278A patent/SE9002278L/ not_active Application Discontinuation
1991
- 1991-06-19 WO PCT/SE1991/000439 patent/WO1992000079A1/en not_active Ceased
- 1991-06-19 AT AT91912558T patent/ATE165514T1/de not_active IP Right Cessation
- 1991-06-19 ES ES91912558T patent/ES2115616T3/es not_active Expired - Lifetime
- 1991-06-19 EP EP91912558A patent/EP0536269B1/de not_active Expired - Lifetime
- 1991-06-19 AU AU81886/91A patent/AU8188691A/en not_active Abandoned
- 1991-06-19 EP EP93101712A patent/EP0554861A1/de not_active Withdrawn
- 1991-06-19 US US07/966,035 patent/US5284839A/en not_active Expired - Fee Related
- 1991-06-19 DK DK91912558T patent/DK0536269T3/da active
- 1991-06-19 DE DE69129331T patent/DE69129331T2/de not_active Expired - Fee Related
- 1991-06-27 JP JP3156823A patent/JPH0639383B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE69129331T2 (de)	1998-09-24
DK0536269T3 (da)	1998-10-07
EP0536269B1 (de)	1998-04-29
SE9002278D0 (sv)	1990-06-28
DE69129331D1 (de)	1998-06-04
ES2115616T3 (es)	1998-07-01
EP0536269A1 (de)	1993-04-14
JPH04230220A (ja)	1992-08-19
US5284839A (en)	1994-02-08
EP0554861A1 (de)	1993-08-11
ATE165514T1 (de)	1998-05-15
JPH0639383B2 (ja)	1994-05-25
AU8188691A (en)	1992-01-23
WO1992000079A1 (en)	1992-01-09

Legal Events

Date	Code	Title	Description
2001-04-02	NAV	Patent application has lapsed	Ref document number: 9002278-1

Publication	Publication Date	Title
DK0536269T3 (da)	1998-10-07	Anvendelse af inositol-triphosphat til fremstilling af medikamenter
KR930702022A (ko)	1993-09-08	인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
IT1241996B (it)	1994-02-02	Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
PT97638A (pt)	1992-02-28	Processo para a preparacao de compostos peptidicos e de composicoes farmaceuticas que os contem
FR2635265B1 (fr)	1995-03-17	Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
IL107157A0 (en)	1993-12-28	Immunopotentiatory agents and pharmaceutical compositions comprising them
DE19875032I2 (de)	2007-04-19	Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
ATE121295T1 (de)	1995-05-15	Augentropfenarzneimittel.
DK0416950T3 (da)	1993-10-11	Medikamenter
PT100973A (pt)	1994-06-30	Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
ATE181505T1 (de)	1999-07-15	Phosphozucker enthaltende pharmazeutische zubereitung
ITMI911147A1 (it)	1992-10-24	Composto ad attivita' terapeutica, sua preparazione e composizioni farmaceutiche che lo contengono
LV10267A (lv)	1994-10-20	Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
SE9403137D0 (sv)	1994-09-20	Derivatives of carbohydrates and compositions containing them
DE69209916D1 (de)	1996-05-23	Oral anzuwendende Arzneimittel Dapiprazol enthaltend
ATE260672T1 (de)	2004-03-15	Pharmazeutische lysin enthaltende polypeptid- zusammensetzungen und verfahren zu deren verwendung
IT9021021A0 (it)	1990-07-23	Composizioni farmaceutiche per la somministrazione orale di irudina
FI903701A0 (fi)	1990-07-23	Reninhaemmande amino-oligohydroxiderivat.
DE69808287D1 (de)	2002-10-31	Pharmazeutische zusammensetzungen von cinchonin dihydrochlorid
DE69902925D1 (de)	2002-10-17	Ramoplaninhaltige neue injizierbare arzneizubereitungen
ATE153241T1 (de)	1997-06-15	Hochdosierte vitamine a-zusammensetzungen
SE9203296D0 (sv)	1992-11-05	The use of inositoltrisphate for the preparing of medicaments
IT9019002A1 (it)	1991-07-03	Composti otticamente attivi per la profilassi dell'insufficienza coronarica acuta e cronica, loro preparazione e composizioni farmaceutiche che li contengono
ITMI912238A1 (it)	1993-02-09	Composti ad attivita' mucolitica e antisettica, procedimento per la loro preparazione e relative composizioni farmaceutiche
ITMI911335A0 (it)	1991-05-15	Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono